Showing results (31-40 of 170) with videos related to
Sort By:
Pageof 17
Brain Research|March 14, 2001
Development of tolerance to nicotine's anxiogenic effect in the social interaction testE E Irvine, S Cheeta, S E FileNeuropharmacology|February 12, 2000
Anxiogenic effects of nicotine in the dorsal hippocampus are mediated by 5-HT1A and not by muscarinic M1 receptorsP J Kenny, S Cheeta, S E FileAddiction (Abingdon, England)|May 2, 2001
A view through the gateway: expectancies as a possible pathway from alcohol to cannabisP WillnerInternational Clinical Psychopharmacology|July 1, 1997
The mesolimbic dopamine system as a target for rapid antidepressant actionP WillnerJournal of Intellectual Disability Research : JIDR|January 7, 2005
The effectiveness of psychotherapeutic interventions for people with learning disabilities: a critical overviewP WillnerThe Mount Sinai Journal of Medicine, New York|June 6, 1998
Reproductive genetics and today's patient options: prenatal diagnosisJ P WillnerOtolaryngologic Clinics of North America|July 14, 2001
Genetic evaluation and counseling in head and neck syndromesJ P WillnerPlos One|December 30, 2016
Unequal Contribution of Widespread and Narrow-Ranged Species to Botanical Diversity PatternsAndré S J van Proosdij, Niels Raes, Jan J Wieringa, et al.Pharmacology, Biochemistry, and Behavior|August 31, 2001
Different treatment regimens and the development of tolerance to nicotine's anxiogenic effectsE E Irvine, S Cheeta, M Marshall, et al.Neuropharmacology|April 20, 2001
Tolerance to midazolam's anxiolytic effects after short-term nicotine treatmentE E Irvine, S Cheeta, C Lovelock, et al.Pageof 17